Cargando…

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants

Current SARS-CoV-2 vaccines provide protection for COVID-19-associated hospitalization and death, but remain inefficient at inhibiting initial infection and transmission. Despite updated booster formulations, breakthrough infections and reinfections from emerging SARS-CoV-2 variants are common. Intr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moser, Michael J., Hill-Batorski, Lindsay, Bowen, Richard A., Matejka, Sarah M., Marshall, David, Kawaoka, Yoshihiro, Neumann, Gabriele, Bilsel, Pamuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302585/ https://www.ncbi.nlm.nih.gov/pubmed/37376452 http://dx.doi.org/10.3390/vaccines11061063

Ejemplares similares

Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge
por: Hill-Batorski, Lindsay, et al.
Publicado: (2023)

10. Quadrivalent M2SR (M2-deficient Single Replication) Live Influenza Vaccine Provides Better Protection Than Inactivated Vaccine Against Drifted Influenza B Virus Challenge in Ferrets
por: Hill-Batorski, Lindsay, et al.
Publicado: (2021)

Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults
por: Eiden, Joseph, et al.
Publicado: (2022)

The Cellular DExD/H-Box RNA Helicase UAP56 Co-localizes With the Influenza A Virus NS1 Protein
por: Chiba, Shiho, et al.
Publicado: (2018)

Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice
por: Sarawar, Sally, et al.
Publicado: (2022)

2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain
por: Eiden, Joseph, et al.
Publicado: (2019)

1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults
por: Eiden, Joseph, et al.
Publicado: (2018)

M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain( )
por: Eiden, Joseph, et al.
Publicado: (2021)

Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults
por: Eiden, Joseph, et al.
Publicado: (2021)

1155. Coadministration of Intranasal M2SR (M2-deficient Single Replication) Investigational Influenza Vaccine with Fluzone High Dose Induces Superior Immune Responses to Fluzone High Dose Alone in 65-85 Year Old Adults
por: Eiden, Joseph, et al.
Publicado: (2023)

33. Intranasal M2SR (M2-deficient Single Replication) Live H3N2 Influenza Investigational Vaccine Induces Serum HAI & Broad Immune Responses in High Proportion of Adults
por: Eiden, Joseph, et al.
Publicado: (2020)

Quo Vadis Influenza?
por: Neumann, Gabriele, et al.
Publicado: (2021)

Predicting the Next Influenza Pandemics
por: Neumann, Gabriele, et al.
Publicado: (2019)

The first influenza pandemic of the new millennium
por: Neumann, Gabriele, et al.
Publicado: (2011)

Seasonality of influenza and other respiratory viruses
por: Neumann, Gabriele, et al.
Publicado: (2022)

Identification of interferon-stimulated genes that attenuate Ebola virus infection
por: Kuroda, Makoto, et al.
Publicado: (2020)

Host Range Restriction and Pathogenicity in the Context of Influenza Pandemic
por: Neumann, Gabriele, et al.
Publicado: (2006)

Identification of mammalian-adapting mutations in the polymerase complex of an avian H5N1 influenza virus
por: Taft, Andrew S., et al.
Publicado: (2015)

Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines
por: Gasper, David J., et al.
Publicado: (2016)

Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector
por: Damjanovic, Daniela, et al.
Publicado: (2008)

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters
por: Deng, Shaofeng, et al.
Publicado: (2023)

A comprehensive map of the influenza A virus replication cycle
por: Matsuoka, Yukiko, et al.
Publicado: (2013)

Influenza H3 hemagglutinin vaccine with scrambled immunodominant epitopes elicits antibodies directed toward immunosubdominant head epitopes
por: Chiba, Shiho, et al.
Publicado: (2023)

Influenza Viruses Suitable for Studies in Syrian Hamsters
por: Fan, Shufang, et al.
Publicado: (2022)

Paradoxical modulation of influenza by intranasal administration of non-replicating adenovirus particles
por: Tang, De-chu Christopher
Publicado: (2020)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Suitability of Polymyxin B as a Mucosal Adjuvant for Intranasal Influenza and COVID-19 Vaccines
por: Yoshino, Naoto, et al.
Publicado: (2023)

Egyptian H5N1 Influenza Viruses—Cause for Concern?
por: Neumann, Gabriele, et al.
Publicado: (2012)

The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics
por: Neumann, Gabriele, et al.
Publicado: (2023)

Which Virus Will Cause the Next Pandemic?
por: Neumann, Gabriele, et al.
Publicado: (2023)

Characterization of H9N2 Avian Influenza Viruses Isolated from Poultry Products in a Mouse Model
por: Murakami, Jurika, et al.
Publicado: (2022)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

H3N2 Influenza Viruses with 12- or 16-Amino Acid Deletions in the Receptor-Binding Region of Their Hemagglutinin Protein
por: Kong, Huihui, et al.
Publicado: (2021)

Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans
por: Yamayoshi, Seiya, et al.
Publicado: (2018)

Amino acid changes in PB2 and HA affect the growth of a recombinant influenza virus expressing a fluorescent reporter protein
por: Katsura, Hiroaki, et al.
Publicado: (2016)

Development of an Enhanced High-Yield Influenza Vaccine Backbone in Embryonated Chicken Eggs
por: Guan, Lizheng, et al.
Publicado: (2023)

Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
por: Nelson, Sean A., et al.
Publicado: (2021)

The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
por: Falkeborn, Tina, et al.
Publicado: (2017)

Functional Analysis of Conserved Motifs in Influenza Virus PB1 Protein
por: Chu, Caroline, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_37tu48datdjhi3i868u14pgo2v